atypical chemokine receptor 2; C-C chemokine receptor 10; C-C chemokine receptor D6; chemokine receptor CCR-10; chemokine receptor CCR-9; chemokine-binding protein 2; chemokine-binding protein D6 (ACKR2, CCBP2, CCR10, CMKBR9, D6)
Jump to navigation
Jump to search
Introduction
The best characterized of the atypical chemokine receptors[3]
Function
- atypical chemokine receptor
- controls chemokine levels & localization via high-affinity chemokine binding uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis
- also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor
- acts as a receptor for chemokines including CCL2, CCL3, CCL3L1, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL22, CCL23, CCL24, SCYA2/MCP-1, SCY3/MIP-1-alpha, SCYA5/RANTES & SCYA7/MCP-3
- upon active ligand stimulation, activates a beta-arrestin 1 (ARRB1)-dependent, G protein-independent signaling pathway that results in the phosphorylation of the actin-binding protein cofilin (CFL1) through a RAC1-PAK1-LIMK1 signaling pathway
- activation of this pathway results in up- regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake & degradation
- by scavenging chemokines in tissues, on the surfaces of lymphatic vessels, & in placenta, plays a role in the resolution (termination) of the inflammatory response & in regulation of adaptive immune responses
- role in immune silencing of macrophages during resolution of inflammation
- acts as a regulator of inflammatory leukocyte interactions with lymphatic endothelial cells
- required for immature/mature dendritic cells discrimination by lymphatic endothelial cells
- phosphorylated on Ser in the C-terminal cytoplasmic tail
- suppresses development of chemically induced skin tumors[2]
Structure
- the C-terminal cytoplasmic tail controls its phosphorylation, stability, intracellular trafficking itinerary, & chemokine scavenging properties
- belongs to the G-protein coupled receptor 1 family atypical chemokine receptor subfamily
Compartment
- early endosome. recycling endosome. cell membrane
- predominantly localizes to endocytic vesicles
- upon ligand stimulation, internalized via clathrin-coated pits
- once internalized, the ligand dissociates from the receptor, & is targeted to degradation while the receptor is recycled back to the cell membrane
Expression
- found in endothelial cells lining afferent lymphatics in dermis & lymph nodes
- also found in lymph nodes subcapsular & medullary sinuses, tonsillar lymphatic sinuses & lymphatics in mucosa & submucosa of small & large intestine & appendix
- expressed on apoptotic neutrophils (at protein level)
- expressed primarily in placenta & fetal liver,
- found at very low levels in the lung & lymph node
- induced by interleukin-6 & interferon-gamma
Pathology
- found in some malignant vascular tumors
- expressed at high levels in Kaposi sarcoma
More general terms
Additional terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/O00590.html
- ↑ 2.0 2.1 Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, Graham GJ. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest. 2007 Jul 2;117(7):1884-1892. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17607362
- ↑ 3.0 3.1 Graham GJ, Locati M. Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6. J Pathol. 2013 Jan;229(2):168-75. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23125030